BUDOTITANE

Possibly Marketed Outside US

Details

Stereochemistry	ACHIRAL
Molecular Formula	2C10H9O2.2C2H5O.Ti
Molecular Weight	460.343
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	-4

SHOW SMILES / InChI

Structure Search

SMILES

[Ti].CC[O-].CC[O-].CC(=O)[CH-]C(=O)C1=CC=CC=C1.CC(=O)[CH-]C(=O)C2=CC=CC=C2

InChI

InChIKey=KAPHMPHWLCJRRK-UHFFFAOYSA-N

InChI=1S/2C10H9O2.2C2H5O.Ti/c2*1-8(11)7-10(12)9-5-3-2-4-6-9;2*1-2-3;/h2*2-7H,1H3;2*2H2,1H3;/q4*-1;

HIDE SMILES / InChI

Molecular Formula	Ti
Molecular Weight	47.867
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C10H10O2
Molecular Weight	162.1852
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C2H5O
Molecular Weight	45.0605
Charge	-1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7988618 | https://www.ncbi.nlm.nih.gov/pubmed/8824351 | https://www.ncbi.nlm.nih.gov/pubmed/2032232 | https://www.ncbi.nlm.nih.gov/pubmed/2775338 | https://www.pharmacologicalsciences.us/anti-tumor/budotitane.html

Budotitane [cis-diethoxybis(1-phenylbutane-1,3-dionato)titanium (IV)] is an inorganic titanium complex. The complex acts as a DNA intercalating agent thereby affecting cell proliferation. Preclinical studies in established screening models indicate considerable antitumor activity. Budotitane reached the end of phase I clinical trials for the treatment of solid tumors.

Approval Year

PubMed

Title	Date	PubMed
Complexes of metals other than platinum as antitumour agents.	1994	7988618
Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane.	1996	8824351

Sample Use Guides

In Vivo Use Guide

Phase I trial dose levels ranged from 100 mg/m2 to 230 mg/m2 twice weekly. Using this schedule, 180 mg/m2 is a safe dose for subsequent clinical studies.

Route of Administration: Intravenous

Substance Class	Chemical Created by `admin` on `Sat Dec 16 16:04:45 GMT 2023` Edited by `admin` on `Sat Dec 16 16:04:45 GMT 2023`
Record UNII	DV05VZD83V
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BUDOTITANE

Official Name

English

DIETHOXYBIS(1-PHENYL-1,3-BUTANEDIONATO)TITANIUM

Common Name

English

budotitane [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C274